TipRanks
Korro Bio (KRRO)
NASDAQ:KRRO
US Market
KRRO
Korro Bio
RESEARCH TOOLSreports
Want to see KRRO full AI Analyst Report?

Korro Bio (KRRO) Stock News & Sentiment

573 Followers
Buy Rating Reiterated on KRRO as Early Clinical Execution, ANCHOR Trial Design and Cash Runway Support Unchanged $21 Price Target
Premium
Ratings
Buy Rating Reiterated on KRRO as Early Clinical Execution, ANCHOR Trial Design and Cash Runway Support Unchanged $21 Price Target
7h ago
KRRO
Korro Bio Begins First Human Trial of KRRO-121 Therapy
Premium
Company Announcements
Korro Bio Begins First Human Trial of KRRO-121 Therapy
21h ago
8K
KRRO
Favorable FDA Readthrough De-Risks Korro’s KRRO-111; Buy Rating Reaffirmed with Unchanged $21 Price Target
Premium
Ratings
Favorable FDA Readthrough De-Risks Korro’s KRRO-111; Buy Rating Reaffirmed with Unchanged $21 Price Target
5d ago
KRRO
Korro Bio Moves KRRO-121 Into First Human Trials, Raising the Stakes in Rare Disease RNA Editing
Premium
Company Announcements
Korro Bio Moves KRRO-121 Into First Human Trials, Raising the Stakes in Rare Disease RNA Editing
2M ago
KRRO
Korro Bio Advances KRRO-121 Into First Human Trial
Premium
Company Announcements
Korro Bio Advances KRRO-121 Into First Human Trial
2M ago
8K
KRRO
Buy Rating Reiterated on Strong Pipeline Progress and Clinical Catalysts; $21 Price Target Unchanged
Premium
Ratings
Buy Rating Reiterated on Strong Pipeline Progress and Clinical Catalysts; $21 Price Target Unchanged
2M ago
KRRO
Korro Bio Retains Buy Rating as Advancing RNA Editing Pipeline and Strong Cash Runway Support Unchanged $15 Price Target
Premium
Ratings
Korro Bio Retains Buy Rating as Advancing RNA Editing Pipeline and Strong Cash Runway Support Unchanged $15 Price Target
2M ago
KRRO
More KRRO News >

KRRO News on the Web

Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), CervoMed (CRVO) and Korro Bio (KRRO)
TipRanks News
Bullish
Korro Bio Advances KRRO-121 Into First Human Trial
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Corbus Pharmaceuticals (CRBP) and Korro Bio (KRRO)
TipRanks News
Neutral
Analyst Reaffirms Buy on Korro Bio, Citing Undervalued OPERA RNA Editing Platform and Multi-Billion-Dollar Pipeline Potential
TipRanks News
Bullish
Korro Bio Stockholders Approve Directors, Pay and Auditor
TipRanks News
Neutral
Korro Bio initiated with an Outperform at LifeSci Capital
TipRanks News
Bullish
Analysts Are Bullish on Top Healthcare Stocks: Korro Bio (KRRO), Veeva Systems (VEEV)
TipRanks News
Bullish
Korro Bio (KRRO) Receives a Buy from H.C. Wainwright
TipRanks News
Bullish

News Score - Last 7 Days

Positive
KRRO
Sector Average
Media Buzz
This Week3 articles
Weekly Average0.25 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KRRO’s Media Buzz Sentiment?
3 articles about KRRO were published this week. In an average week, 0.25 articles are published.
    What is KRRO’s weekly average amount of articles?
    In an average week, 0.25 articles about KRRO are published.
      What is KRRO’s News Sentiment?
      100% of articles about KRRO were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        XERSXeris Pharmaceuticals
        QTTBQ32 Bio
        ABTAbbott Laboratories
        GMABGenmab
        BAYRYBayer
        Showing the stocks with the most bullish news sentiment over the past week